MNT daily newsletter - December 03, 2018

Medical News Today

Dear S.C.T.C,

Welcome to today's MNT newsletter, containing the most recent headlines from your chosen news categories.


Biology / Biochemistry
Type 1 diabetes: Drawing nearer to treatment that generates new insulin cells
Scientists have mapped the signals in the cellular environment that determine whether immature pancreatic cells will produce insulin.


Cardiovascular / Cardiology
The health risks of being a night owl
In a comprehensive review, researchers have investigated the impact of being a night owl on eating patterns and evaluated associated health risks.


Cosmetic Medicine / Plastic Surgery
Surgeons successfully perform full face transplant
With the help of innovative techniques, surgeons at New York University Langone Health have successfully conducted a full face transplant.


Diabetes
Type 1 diabetes: Drawing nearer to treatment that generates new insulin cells
Scientists have mapped the signals in the cellular environment that determine whether immature pancreatic cells will produce insulin.
The health risks of being a night owl
In a comprehensive review, researchers have investigated the impact of being a night owl on eating patterns and evaluated associated health risks.


Diabetes Type 1
Type 1 diabetes: Drawing nearer to treatment that generates new insulin cells
Scientists have mapped the signals in the cellular environment that determine whether immature pancreatic cells will produce insulin.


Food Intolerance
Celiac disease may be treated with cystic fibrosis drugs
New research investigates the similarities between cystic fibrosis and celiac disease, suggesting that drugs for the former may also treat the latter.


GastroIntestinal / Gastroenterology
Celiac disease may be treated with cystic fibrosis drugs
New research investigates the similarities between cystic fibrosis and celiac disease, suggesting that drugs for the former may also treat the latter.


Immune System / Vaccines
Celiac disease may be treated with cystic fibrosis drugs
New research investigates the similarities between cystic fibrosis and celiac disease, suggesting that drugs for the former may also treat the latter.


Medical Innovation
Surgeons successfully perform full face transplant
With the help of innovative techniques, surgeons at New York University Langone Health have successfully conducted a full face transplant.


Nutrition / Diet
Celiac disease may be treated with cystic fibrosis drugs
New research investigates the similarities between cystic fibrosis and celiac disease, suggesting that drugs for the former may also treat the latter.


Psychology / Psychiatry
Social media photo overkill may boost narcissism
Findings of a recent study suggest that individuals most likely to post photos of themselves on social media may develop higher levels of narcissism.


Sleep / Sleep Disorders / Insomnia
The health risks of being a night owl
In a comprehensive review, researchers have investigated the impact of being a night owl on eating patterns and evaluated associated health risks.


Stem Cell Research
Type 1 diabetes: Drawing nearer to treatment that generates new insulin cells
Scientists have mapped the signals in the cellular environment that determine whether immature pancreatic cells will produce insulin.


Surgery
Surgeons successfully perform full face transplant
With the help of innovative techniques, surgeons at New York University Langone Health have successfully conducted a full face transplant.


Chat with MNT on Facebook Messenger

Get the latest MNT news in Facebook Messenger. Chat with us now!

Just send us a message from our Facebook page.

Alternatively, use this link to chat directly on Messenger.


You are receiving this newsletter because you subscribed through your MNT account on our web site, Medical News Today. If you wish to alter any of your subscription details (name, email address etc) or chosen news categories, please log into log into your newsletter preferences page.

To unsubscribe from these newsletters immediately, please click here.



No comments:

Post a Comment